Jakub Szulc, director of life sciences at EY Poland, discusses the exciting opportunities that exist within the healthcare sector in the flourishing Polish economy and the overriding need to increase healthcare spending as the nation prepares for demographic changes in the future. Furthermore, he highlights the innovative services EY provides and the strategies moving forward as the company consolidates its leading position within the Big Four.
What was your mission when you took up this role three years ago?
"In the healthcare market, Poland is safe to invest, no matter the regulations."
